Page last updated: 2024-09-05

sorafenib and Biliary Cirrhosis

sorafenib has been researched along with Biliary Cirrhosis in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Heller, J; Hennenberg, M; Kohistani, AZ; Sauerbruch, T; Stark, C; Trebicka, J	1
Fehér, J; Lengyel, G	1
Fischer, HP; Granzow, M; Heller, J; Hennenberg, M; Klein, S; Kohistani, Z; Körner, C; Krämer, B; Nischalke, HD; Sauerbruch, T; Stark, C; Trebicka, J	1
Chang, CC; Chuang, CL; Hsieh, HG; Hsu, SJ; Huang, HC; Lee, FY; Lee, SD; Lin, HC; Teng, TH; Wang, SS	1

Reviews

1 review(s) available for sorafenib and Biliary Cirrhosis

Article	Year
[Hepatocellular carcinoma: occurrence, risk factors, biomarkers]. Orvosi hetilap, 2010, Jun-06, Volume: 151, Issue:23 Topics: Antineoplastic Agents; Benzenesulfonates; Biomarkers, Tumor; Carcinoma, Hepatocellular; Copper; Developed Countries; Developing Countries; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Incidence; Iron; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Liver Neoplasms; Metabolic Diseases; Niacinamide; Phenylurea Compounds; Pyridines; Risk Factors; Smoking; Sorafenib	2010

Article

Year

[Hepatocellular carcinoma: occurrence, risk factors, biomarkers].

Orvosi hetilap, 2010, Jun-06, Volume: 151, Issue:23

Topics: Antineoplastic Agents; Benzenesulfonates; Biomarkers, Tumor; Carcinoma, Hepatocellular; Copper; Developed Countries; Developing Countries; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Incidence; Iron; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Liver Neoplasms; Metabolic Diseases; Niacinamide; Phenylurea Compounds; Pyridines; Risk Factors; Smoking; Sorafenib

2010

Other Studies

3 other study(ies) available for sorafenib and Biliary Cirrhosis

Article	Year
Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis. British journal of pharmacology, 2009, Volume: 157, Issue:2 Topics: Animals; Aorta; Benzenesulfonates; Blotting, Western; Hypertension, Portal; Liver; Liver Cirrhosis, Biliary; Male; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; rho-Associated Kinases; Signal Transduction; Sorafenib	2009
Hepatic and HSC-specific sorafenib effects in rats with established secondary biliary cirrhosis. Laboratory investigation; a journal of technical methods and pathology, 2011, Volume: 91, Issue:2 Topics: Actins; Animals; Apoptosis; Benzenesulfonates; Caspase 3; Colorimetry; DNA Fragmentation; Hepatic Stellate Cells; Histological Techniques; Hypertension, Portal; Immunohistochemistry; Liver; Liver Cirrhosis, Biliary; Niacinamide; Phenylurea Compounds; Poly(ADP-ribose) Polymerases; Protein Kinase Inhibitors; Pyridines; Rats; Sorafenib; Vascular Resistance	2011
Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis. Clinical science (London, England : 1979), 2013, Volume: 124, Issue:7 Topics: Animals; Benzenesulfonates; Common Bile Duct; Disease Models, Animal; Hemodynamics; Hepatopulmonary Syndrome; Ligation; Liver; Liver Cirrhosis, Biliary; Liver Diseases; Lung; Male; Niacinamide; Oxygen; Partial Pressure; Phenylurea Compounds; Pyridines; Rats; Rats, Sprague-Dawley; Sorafenib; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2	2013